Log In
Print
BCIQ
Print
Print this Print this
 

anti-PrP antibody (AMF-1c-120)

  Manage Alerts
Collapse Summary General Information
Company Amorfix Life Sciences Ltd.
DescriptionAntibody-drug conjugate (ADC) composed of an anti-misfolded prion protein (PRNP; PrP; CD230) antibody and urease
Molecular Target Prion protein (PRNP) (PrP) (CD230)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation

Partner

Apexigen Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today